HealthTronics closes AMPI buy:
This article was originally published in Clinica
Executive Summary
In a bid to diversify its urology product line, HealthTronics has bought urological cryosurgery specialist Advanced Medical Partners (AMPI) for an undisclosed fee. The deal saw HealthTronics pay a cash-and-stock mix to AMPI at the closing - AMPI will also receive performance-related earn-out payments. AMPI recorded revenues of over $24m in 2007. According to Austin, Texas-based HealthTronics, this acquisition will make it the largest provider of shock wave lithotripsy and cryosurgery services in the US. HealthTronics said it expects AMPI to provide top- and bottom- line synergies, thus enabling cost savings. In conjunction with the acquisition, HealthTronics also announced 2008 revenue guidance of $160-162m, and an operating profit target of $20-21m.
You may also be interested in...
Listerine, Tylenol Push J&J Consumer Health To 2020 Finish Line Against Pandemic Weight
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.
NB Pure Rolls Out As Brand For Sharpening Consumer Attention On Natural Wellness Line
Nutritional Brands rolls out NB Pure as brand, including logo, packaging design and website, for all its supplements after 25 years. “When you looked at our label for one brand and looked at the label for another brand, there was no symmetry between the two,” says CEO Danna Pratt.
Sanofi Steps Up To Lend A Hand Producing Pfizer/BioNTech's COVID-19 Vaccine In Europe
Sanofi will fill and package 100 million doses of a rival vaccine for the European market in 2021 in a sign of how the industry is working to meet an unprecedented demand for COVID-19 vaccines.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: